Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short Course Low Dose Oral Colchicine After STEMI
NCT06020300Phase 4Unknown
- Sponsor
- Universiti Kebangsaan Malaysia
- Start
- Jul 2023
- Primary completion
- Dec 2023
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ST elevation myocardial infarction (STEMI) comparing Colchicine with Placebo (2 arms). Primary endpoints: Anti-Inflammatory Effect of Colchicine and Major Adverse Cardiac Events at 3 months. Status: unknown.
02
Drugs
colchicine
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT06020300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06020300.